CA2534871A1 - Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide - Google Patents

Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide Download PDF

Info

Publication number
CA2534871A1
CA2534871A1 CA 2534871 CA2534871A CA2534871A1 CA 2534871 A1 CA2534871 A1 CA 2534871A1 CA 2534871 CA2534871 CA 2534871 CA 2534871 A CA2534871 A CA 2534871A CA 2534871 A1 CA2534871 A1 CA 2534871A1
Authority
CA
Canada
Prior art keywords
thyroid
expression
ccnd2
pcsk2
plab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2534871
Other languages
English (en)
Other versions
CA2534871C (fr
Inventor
Charis Eng
Frank Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2534871A priority Critical patent/CA2534871C/fr
Publication of CA2534871A1 publication Critical patent/CA2534871A1/fr
Application granted granted Critical
Publication of CA2534871C publication Critical patent/CA2534871C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2534871A 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide Expired - Fee Related CA2534871C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2534871A CA2534871C (fr) 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2534871A CA2534871C (fr) 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide

Publications (2)

Publication Number Publication Date
CA2534871A1 true CA2534871A1 (fr) 2007-08-15
CA2534871C CA2534871C (fr) 2015-08-04

Family

ID=38421204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2534871A Expired - Fee Related CA2534871C (fr) 2006-02-15 2006-02-15 Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide

Country Status (1)

Country Link
CA (1) CA2534871C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9175076B2 (en) 2012-12-21 2015-11-03 Aveo Pharmaceuticals, Inc. Anti-GDF15 antibodies
EP3034620A1 (fr) * 2014-12-17 2016-06-22 Diaxonhit Compositions et procédés permettant de diagnostiquer un cancer de la thyroïde
CN109321645A (zh) * 2018-10-23 2019-02-12 深圳市慧思基因科技有限公司 一种端粒酶催化蛋白亚单位hTERT活性的检测方法
CN113222928A (zh) * 2021-05-07 2021-08-06 北京大学第一医院 一种尿细胞学人工智能尿路上皮癌识别系统

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9175076B2 (en) 2012-12-21 2015-11-03 Aveo Pharmaceuticals, Inc. Anti-GDF15 antibodies
US9725505B2 (en) 2012-12-21 2017-08-08 Aveo Pharmaceuticals, Inc. Methods of treatment using anti-GDF15 antibodies
US10597444B2 (en) 2012-12-21 2020-03-24 Aveo Pharmaceuticals, Inc. Anti-GDF15 antibodies
US11725047B2 (en) 2012-12-21 2023-08-15 Aveo Pharmaceuticals, Inc. Anti-GDF-15 antibodies
EP3034620A1 (fr) * 2014-12-17 2016-06-22 Diaxonhit Compositions et procédés permettant de diagnostiquer un cancer de la thyroïde
WO2016097059A1 (fr) * 2014-12-17 2016-06-23 Diaxonhit Compositions et procédés pour le diagnostic du cancer de la thyroïde
CN109321645A (zh) * 2018-10-23 2019-02-12 深圳市慧思基因科技有限公司 一种端粒酶催化蛋白亚单位hTERT活性的检测方法
CN113222928A (zh) * 2021-05-07 2021-08-06 北京大学第一医院 一种尿细胞学人工智能尿路上皮癌识别系统
CN113222928B (zh) * 2021-05-07 2023-09-19 北京大学第一医院 一种尿细胞学人工智能尿路上皮癌识别系统

Also Published As

Publication number Publication date
CA2534871C (fr) 2015-08-04

Similar Documents

Publication Publication Date Title
US7670775B2 (en) Method for differentiating malignant from benign thyroid tissue
Weber et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination
CA2862993C (fr) Marqueurs urinaires permettant de detecter un cancer de la vessie
CA2693847C (fr) Methode de diagnostic et/ou de pronostic d'un cancer vesical
EP2227568B1 (fr) Diagnostic moléculaire in vitro du cancer du sein
EP3056576B1 (fr) Procédé permettant de diagnostiquer des néoplasmes
EP2420575B1 (fr) Marqueur pronostique du cancer du foie
CA2504403A1 (fr) Pronostic d'une malignite hematologique
CA2534871A1 (fr) Test a trois genes pour differencier les nodules malins des nodules benins au niveau de la thyroide
AU2020200168B2 (en) Urine markers for detection of bladder cancer
EP2634267B1 (fr) Délétion d'ADN mitochondrial de 3,4 kb pour utilisation dans la détection du cancer
AU2011236061B2 (en) Urine markers for detection of bladder cancer
AU2014224523A1 (en) Molecular markers in bladder cancer
EP3339450A2 (fr) Marqueurs moléculaires dans le cancer de la vessie
NZ584549A (en) HOXA13 urine marker for detection of bladder cancer

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210831

MKLA Lapsed

Effective date: 20200217